Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis

Completed · Phase 4 · Has a placebo group

Conditions studied: Perennial Allergic Rhinitis

In brief

The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.

Key facts

Study ID

NCT00894231

Run by

AAADRS Clinical Research Center

People needed

30

Starts

2009-01-01

Expected to finish

2009-08-01

Last updated by the study team

2009-09-04

Who can join

Age: 12 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ICF signed
• Diagnosis of PAR for 6-12 months greater
• 12 years and older
• Decreased nasal NO values at baseline
• Compliance and ability to perform maneuvers and responsibilities

You may not qualify if…

• Oral or systemic steroids for 60 days prior
• Inhaled, nasal, nebulized steroids w/i 4 weeks
• Hospitalization or life threatening asthma
• Use of nasal or oral antihistamines w/i 4 weeks
• Upper or lower airways infection
• Direct cigarette smoke exposure

Where it is running

• AAADRS — Coral Gables, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.